NCT02180412View on ClinicalTrials.gov

Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 28, 2014

Primary Completion Date

February 3, 2022

Study Completion Date

February 3, 2022

Conditions
Acute Porphyrias
Interventions
BIOLOGICAL

Panhematin

Glucose loading

OTHER

Glucose

Glucose is administered to both groups as routine care.

Trial Locations (1)

77555

University of Texas Medical Branch, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT02180412 - Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria | Biotech Hunter | Biotech Hunter